Lung Cancer remains the leading cause of cancer-related deaths worldwide. A recent clinical trial has shown promising results in lung cancer patients. Amgen AMGN has announced positive results from a phase III…
Category: Lung Cancer Treatment
Get to know about types of lung cancer treatment methods, causes, researches, early symptoms and stages. To know more details about the lung cancers browse the website.
Younger Lung Cancer Patients Have More Targetable Genetic Changes
According to a large international study led in part by researchers at Sylvester Comprehensive Cancer Centre part of the University of Miami Miller School of Medicine, younger adults with non-small cell lung…
Study: Biological Sex Linked To Protein Changes In Lung Cancer
A new study from the Sanford Burnham Prebys Medical Discovery Institute has revealed that biological sex is associated with cancer incidence, its progression and drug response. It has characterized sex differences across…
American Scientists Explore New Way to Slow Down Lung Cancer
Lung Cancer remains one of the deadliest forms of cancers and is responsible for taking many lives every year all around the world. Continuous research works and studies are being conducted to…
Study: Extending Lung Transplant to Stage 4 Cancer Patients
A new Northwestern Medicine study has been published in JAMA. It suggested that lung transplantation can be extended to some patients with stage 4 lung cancer. The study was conducted as a…
Roche KRAS Drug, Divarasib, Showed Strong Results in Lung Cancer Treatment
Despite various advancements in treatment, lung cancer remains the leading cause of cancer-related deaths. It is responsible for claiming lives of 1.8 million people with non-small cell lung cancer accounting for about…
Lilly Launches Cancer Therapy Tanstrive (Selpercatinib) in India
Eli Lilly has launched Tanstrive (selpercatinib) in India for patients with advanced or metastatic cancers driven by alterations in the RET gene. Selpercatinib is a targeted therapy that works to block abnormal…
Merck-Kelun Lung Cancer Drug Outperforms Keytruda in Trial
According to Phase 3 study results, Merck-Kelun combo can reduce the risk of tumor progression by 65% in patients with lung cancer. The study has been conducted in China and is the…